Immortality Reconsidered: Clinical Challenges at the Frontier of Plastic Surgery
Journal of Clinical Medicine · 10.11.2025 · 14 (22) · 7973
DOI: 10.3390/jcm14227973 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.11.2025. Verfasst von Helen Xun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Immortality and anti-aging research is accelerating, with implications across medicine. This narrative review explores the biological principles, translational innovations, and ethical considerations at the intersection of aging and plastic surgery, reframed for a broad clinical audience.
Methods
A narrative review of the literature from PubMed, clinical trials, and translational studies was conducted, with emphasis on regenerative medicine, stem cells, tissue engineering, gene editing, and longevity pharmacologics within the field of plastic and reconstructive surgery.
Results
Key themes include (1) the biology of aging and epigenetic reprogramming, (2) esthetic and regenerative innovations with broader clinical significance, (3) emerging genetic and pharmacologic longevity strategies, (4) ethical and regulatory challenges, and (5) future directions such as nanotechnology, artificial intelligence, and digital immortality.
Conclusions
Immortality remains an aspirational frontier, but innovations in regenerative science and longevity research offer opportunities for improving healthspans. Medicine as a whole must balance innovation with ethics, equity, and safety in translating these discoveries to patient care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
- Division of Plastic and Reconstructive Surgery, Shanghai Fourth People's Hospital, Tongji University, Shanghai 200070, China.
- Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, PA 15260, USA.
- Division of Plastic and Reconstructive Surgery, Mayo Clinic, Jacksonville, FL 32224, USA.
- St. John's Regional Medical Center, Oxnard, CA 93030, USA.
ORCID-Profile: Helen Xun, Sarvam TerKonda, Bernard T Lee
Zitieren
APA
Xun, H., Mustoe, A. K., Escobar, M. J., Chan, Z., Moreira, A., TerKonda, S., Jeffers, L., & Lee, B. T. (2025). Immortality Reconsidered: Clinical Challenges at the Frontier of Plastic Surgery. Journal of Clinical Medicine, 14(22), 7973. https://doi.org/10.3390/jcm14227973
Vancouver
Xun H, Mustoe AK, Escobar MJ, Chan Z, Moreira A, TerKonda S, et al. Immortality Reconsidered: Clinical Challenges at the Frontier of Plastic Surgery. Journal of Clinical Medicine. 2025;14(22):7973. doi:10.3390/jcm14227973
BibTeX
@article{Xun2025,
author = {Xun, Helen and Mustoe, Audrey K and Escobar, Maria J and Chan, Zion and Moreira, Andrea and TerKonda, Sarvam and Jeffers, Lynn and Lee, Bernard T},
title = {Immortality Reconsidered: Clinical Challenges at the Frontier of Plastic Surgery},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {22},
pages = {7973},
doi = {10.3390/jcm14227973}
}
EUVIMED